Title : Preclinical evaluation of sorafenib-eluting stent for suppression of human cholangiocarcinoma cells.

Pub. Date : 2013

PMID : 23658488






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Anticancer activity of sorafenib against HuCC-T1 cells was evaluated by the proliferation test, matrix metalloproteinase (MMP) activity, cancer cell invasion, and angiogenesis assay in vitro and in vivo. Sorafenib matrix metallopeptidase 2 Homo sapiens
2 MMP-2 expression of HuCC-T1 cells gradually decreased according to sorafenib concentration. Sorafenib matrix metallopeptidase 2 Homo sapiens